FHIT、MDM2在CIN和宫颈鳞癌组织中的表达及临床意义
摘要
背景与目的
在世界范围内,宫颈癌是妇女癌症中仅次于乳腺癌而位居第二的恶性肿瘤。在我国宫颈癌是最常见的妇科恶性肿瘤,且发生率有继续增加和年轻化趋势。目前,其发病机制尚不完全清楚。癌基因的激活、抑癌基因的失活是肿瘤发生的重要机制之一。
脆性组氨酸三联体(fragile histidine triad, FHIT)是一种候选抑癌基因。FHIT蛋白通过诱导细胞调亡、调控细胞周期,参与微管形成等发挥抑癌作用。它的表达对肿瘤的发生、发展、肿瘤分化、侵袭性和转移有着重要影响。鼠双微体2(murine double minute2, MDM2)为癌基因,编码泛素-蛋白连接酶,MDM2基因扩增或MDM2蛋白过度表达可以负性调节p53蛋白的稳定性和转录活性,限制其肿瘤抑制功能的发挥,使细胞获得更强的促进细胞转化和恶变的能力。
本文旨在研究FHIT和MDM2在慢性宫颈炎宫颈组织、宫颈上皮内瘤变(CIN)、宫颈鳞癌组织中的表达,及其与宫颈鳞癌临床病理特点的关系,并探讨FHIT和MDM2在宫颈鳞癌发生发展中的作用。
材料与方法
1、实验分组
组织标本均来源于郑州大学第二附属医院病理科,选取2009年9月至2011年7月库存标本,均经过石蜡包埋法处理,其中宫颈鳞状细胞癌的组织标本50例,宫颈上皮内瘤变组织标本40例(CIN1为20例,CIN2-3为20例),并取同期住院的(因子宫良性病变行子宫全切术)慢性宫颈炎宫颈组织20例作为对照。所有的宫颈病变患者术前均未接受放疗或／和化疗。
2、实验方法
应用免疫组织化学即S-P法检测FHIT和MDM2蛋白在慢性宫颈炎、CIN、宫颈鳞癌组织中的表达情况。
3、统计方法
运用SPSS17.0软件包进行数据的统计学相关的分析,采用x2检验的方法,比较组间的差异,两因子的相关性采用2×2配对资料的关联性分析法进行统计分析,以a=0.05为检验水准,若P<0.05即认为差异有统计学意义。
结果1.FHIT蛋白在不同宫颈组织中的表达
FHIT蛋白在对照组、CIN组、宫颈鳞癌组组织中的阳性表达水平呈下降趋势,在对照组中的表达明显高于CIN组(χ2=4.335,P<0.05)和宫颈鳞癌组(χ2=22.256,P<0.05),CIN Ⅰ组与CIN Ⅱ-Ⅲ组该蛋白差异表达无统计意义(P>0.05)；CIN组与宫颈鳞癌组组织中FHIT蛋白的差异表达有统计学意义(χ2=12.266,P<0.05)。FHIT蛋白的表达与宫颈鳞癌患者的年龄、临床分期无明显相关性(P>0.05),与组织分化、淋巴转移情况相关(P<0.05)。
2.MDM2蛋白在不同宫颈组织中的表达
MDM2蛋白在对照组、CIN组、宫颈鳞癌组组织中的阳性表达水平呈上升趋势,在对照组中的表达明显低于CIN组(χ2=5.294,P<0.05)和宫颈鳞癌组(χ2=22.256,P<0.05),CIN Ⅰ组与CIN Ⅱ-Ⅲ组该蛋白无明显差异表达(P>0.05)；CIN组与宫颈鳞癌组组织中MDM2蛋白的差异表达有统计学意义(χ2=14.042,P<0.05)。MDM2蛋白的表达与宫颈鳞癌患者的年龄无明显相关(P>0.05),与临床分期、组织分化、淋巴转移情况相关(P<0.05)。
3. FHIT和MDM2在宫颈鳞癌中表达情况的相关性
分析得出FHIT和MDM2在宫颈鳞癌组织中表达呈负相关(χ2=16.563,r=-0.576,P<0.01)。
结论
1. FHIT蛋白可能参与宫颈鳞癌的发生。
2.MDM2蛋白可能参与宫颈鳞癌的发生和进展过程。
3. FHIT、MDM2蛋白可能与宫颈鳞癌的转移相关。
4. FHIT、MDM2蛋白的表达在宫颈鳞癌组呈负相关,提示FHIT蛋白表达降低和MDM2蛋白表达升高可能促进了肿瘤的恶性增殖及转移。
Background and Purpose
Carcinoma of the cervix is the second most common gynecological malignancy among women worldwide, whose incidence rate is merely lower than breast cancer. In our country there is a rising trend in incident rate and incidence of young patient with cervical cancer. So far the exact etiology and pathogenesis of cervical cancer remains unknown. The activation of oncogene and inactivation of anti-oncogene is one of mechanisms of tumorigenesis.
Fragile histidine triad (FHIT) is one of candidate anti-oncogenes. FHIT plays a role by inducing cell apoptosis and regulating cell cycle and participating in formation of microtubules. The expression of FHIT can affect tumor occurrence and development,also differentiation,invasion and metastasis notablely. Murine double minute2(MDM2) is one of oncogenes. The amplification of mdm2gene and over expression of mdm2protein can regulate P53gene negatively and limit its role as a tumor suppressor, acquired ability of facilitating cell transformation and canceration.
This article aims to study the expression of FHIT and MDM2in chronic cervicitis, cervical intraepithelial neoplasia (CIN), cervical squamons cell carcinoma,and their clinicopathologic relationships with cervical squamons cell carcinoma, investigating the role of FHIT and MDM2in occurrence and development of cervical cancer.
Materal and Methods
1. Grouping
All tissue samples were collected from the department of pathology of the Second Affiliated Hospital of Zhengzhou University from September2009to July2011. They were all embeded in paraffin.50cases of cervical squamous cell cancer and40cases of CIN (including20cases of CIN I and20cases of CINⅡ-Ⅲ) were treated as the experimental groups.20cases of chronic cervicitis tissue which were gained by total hysterectomy because of benign uterine diseases were treated as the control group. None of these patients received treatments with rideotherapy and/or chemotherapy before surgery.
2. Method
Streptavidin-peroxidase immunostaining (SP) method was used to detect the expression of FHIT and MDM2in the tissues of chronic cervicitis, CIN and cervical squamons cell carcinoma.
3. Statistical analysis
All of the data analysis was performed with statisticial software package SPSS17.0version. Chi-square test was applied in comparing differences between experimental group and control group. Correlation between FHIT and MDM2was analysied by using2x2Contingency Table. The standard statistically significance level was alpha=0.05.
Results
1. The expression of FHIT
The positive expression rates of FHIT displayed a decreasing level from chronic cervicitis group,different CIN groups to cervical cancer group.The positive expression of FHIT in chronic cervicitis tissus was significantly higher than in CIN tissues (χ2=4.335, P<0.05) and cervical squamous cell cancer tissus (χ2=22.256, P<0.05).There was no statistically difference between CIN I and CIN II-III(P>0.05).There was statistically differrence between CIN group and squamous cell cancer group (χ2=12.266, P<0.05). The positive expression of FHIT in cervical squamons cell cancer groups was related to histological grading and lymph node metastasis,(P<0.05), which had nothing to do with the pathological type and age (P>0.05).
2. The expression of MDM2
The positive expression rates of MDM2displayed a increasing level from chronic cervicitis group,different CIN groups to cervical cancer group. The positive expression of MDM2in chronic cervicitis tissues was significantly lower than in CIN tissues (χ2=5.294, P<0.05)and cervical squannous cellcancer tissus (χ2=22.256, P<0.05). There was no statistically difference between CIN I and CIN Ⅱ-Ⅲ (P>0.05).There was statistically differrence between CIN group and squamous cancer group (χ2=14.042, P<0.05). The expression of MDM2in different cervical squamons cancer groups was not corelated with different ages (P>0.05),but significantly related with clinical stage, histological grade and lymph node mestastasis (P<0.05). The positive expression of MDM2in cervical squamons cell cancer groups was related to pathological type,histological grading and lymph node metastasis,(P<0.05), which had nothing to do with age (P>0.05).
3. The correlation between FHIT and MDM2in different cervical squa-mous cell cancer tissues
The expression of FHIT and MDM2were obviously inverse correlation (χ2=16.563,r=-0.576,P<0.01)
Conclusions
1. FHIT might play an important role in the occurence of cervical squamous cell carcinoma.
2. MDM2might participate in the occurence and development of cervical squamous cell carcinoma.
3. Both FHIT and MDM2might participate in the metasitasis of cervical squamous cell carcinoma.
4. The FHIT expression was negatively correlated to MDM2expression, indicating that loss expression of FHIT and overexpression of MDM2might promote proliferation and metastasis of malignant tumor.
在世界范围内,宫颈癌是妇女癌症中仅次于乳腺癌而位居第二的恶性肿瘤。在我国宫颈癌是最常见的妇科恶性肿瘤,且发生率有继续增加和年轻化趋势。目前,其发病机制尚不完全清楚。癌基因的激活、抑癌基因的失活是肿瘤发生的重要机制之一。
脆性组氨酸三联体(fragile histidine triad, FHIT)是一种候选抑癌基因。FHIT蛋白通过诱导细胞调亡、调控细胞周期,参与微管形成等发挥抑癌作用。它的表达对肿瘤的发生、发展、肿瘤分化、侵袭性和转移有着重要影响。鼠双微体2(murine double minute2, MDM2)为癌基因,编码泛素-蛋白连接酶,MDM2基因扩增或MDM2蛋白过度表达可以负性调节p53蛋白的稳定性和转录活性,限制其肿瘤抑制功能的发挥,使细胞获得更强的促进细胞转化和恶变的能力。
本文旨在研究FHIT和MDM2在慢性宫颈炎宫颈组织、宫颈上皮内瘤变(CIN)、宫颈鳞癌组织中的表达,及其与宫颈鳞癌临床病理特点的关系,并探讨FHIT和MDM2在宫颈鳞癌发生发展中的作用。
材料与方法
1、实验分组
组织标本均来源于郑州大学第二附属医院病理科,选取2009年9月至2011年7月库存标本,均经过石蜡包埋法处理,其中宫颈鳞状细胞癌的组织标本50例,宫颈上皮内瘤变组织标本40例(CIN1为20例,CIN2-3为20例),并取同期住院的(因子宫良性病变行子宫全切术)慢性宫颈炎宫颈组织20例作为对照。所有的宫颈病变患者术前均未接受放疗或／和化疗。
2、实验方法
应用免疫组织化学即S-P法检测FHIT和MDM2蛋白在慢性宫颈炎、CIN、宫颈鳞癌组织中的表达情况。
3、统计方法
运用SPSS17.0软件包进行数据的统计学相关的分析,采用x2检验的方法,比较组间的差异,两因子的相关性采用2×2配对资料的关联性分析法进行统计分析,以a=0.05为检验水准,若P<0.05即认为差异有统计学意义。
结果1.FHIT蛋白在不同宫颈组织中的表达
FHIT蛋白在对照组、CIN组、宫颈鳞癌组组织中的阳性表达水平呈下降趋势,在对照组中的表达明显高于CIN组(χ2=4.335,P<0.05)和宫颈鳞癌组(χ2=22.256,P<0.05),CIN Ⅰ组与CIN Ⅱ-Ⅲ组该蛋白差异表达无统计意义(P>0.05)；CIN组与宫颈鳞癌组组织中FHIT蛋白的差异表达有统计学意义(χ2=12.266,P<0.05)。FHIT蛋白的表达与宫颈鳞癌患者的年龄、临床分期无明显相关性(P>0.05),与组织分化、淋巴转移情况相关(P<0.05)。
2.MDM2蛋白在不同宫颈组织中的表达
MDM2蛋白在对照组、CIN组、宫颈鳞癌组组织中的阳性表达水平呈上升趋势,在对照组中的表达明显低于CIN组(χ2=5.294,P<0.05)和宫颈鳞癌组(χ2=22.256,P<0.05),CIN Ⅰ组与CIN Ⅱ-Ⅲ组该蛋白无明显差异表达(P>0.05)；CIN组与宫颈鳞癌组组织中MDM2蛋白的差异表达有统计学意义(χ2=14.042,P<0.05)。MDM2蛋白的表达与宫颈鳞癌患者的年龄无明显相关(P>0.05),与临床分期、组织分化、淋巴转移情况相关(P<0.05)。
3. FHIT和MDM2在宫颈鳞癌中表达情况的相关性
分析得出FHIT和MDM2在宫颈鳞癌组织中表达呈负相关(χ2=16.563,r=-0.576,P<0.01)。
结论
1. FHIT蛋白可能参与宫颈鳞癌的发生。
2.MDM2蛋白可能参与宫颈鳞癌的发生和进展过程。
3. FHIT、MDM2蛋白可能与宫颈鳞癌的转移相关。
4. FHIT、MDM2蛋白的表达在宫颈鳞癌组呈负相关,提示FHIT蛋白表达降低和MDM2蛋白表达升高可能促进了肿瘤的恶性增殖及转移。
Background and Purpose
Carcinoma of the cervix is the second most common gynecological malignancy among women worldwide, whose incidence rate is merely lower than breast cancer. In our country there is a rising trend in incident rate and incidence of young patient with cervical cancer. So far the exact etiology and pathogenesis of cervical cancer remains unknown. The activation of oncogene and inactivation of anti-oncogene is one of mechanisms of tumorigenesis.
Fragile histidine triad (FHIT) is one of candidate anti-oncogenes. FHIT plays a role by inducing cell apoptosis and regulating cell cycle and participating in formation of microtubules. The expression of FHIT can affect tumor occurrence and development,also differentiation,invasion and metastasis notablely. Murine double minute2(MDM2) is one of oncogenes. The amplification of mdm2gene and over expression of mdm2protein can regulate P53gene negatively and limit its role as a tumor suppressor, acquired ability of facilitating cell transformation and canceration.
This article aims to study the expression of FHIT and MDM2in chronic cervicitis, cervical intraepithelial neoplasia (CIN), cervical squamons cell carcinoma,and their clinicopathologic relationships with cervical squamons cell carcinoma, investigating the role of FHIT and MDM2in occurrence and development of cervical cancer.
Materal and Methods
1. Grouping
All tissue samples were collected from the department of pathology of the Second Affiliated Hospital of Zhengzhou University from September2009to July2011. They were all embeded in paraffin.50cases of cervical squamous cell cancer and40cases of CIN (including20cases of CIN I and20cases of CINⅡ-Ⅲ) were treated as the experimental groups.20cases of chronic cervicitis tissue which were gained by total hysterectomy because of benign uterine diseases were treated as the control group. None of these patients received treatments with rideotherapy and/or chemotherapy before surgery.
2. Method
Streptavidin-peroxidase immunostaining (SP) method was used to detect the expression of FHIT and MDM2in the tissues of chronic cervicitis, CIN and cervical squamons cell carcinoma.
3. Statistical analysis
All of the data analysis was performed with statisticial software package SPSS17.0version. Chi-square test was applied in comparing differences between experimental group and control group. Correlation between FHIT and MDM2was analysied by using2x2Contingency Table. The standard statistically significance level was alpha=0.05.
Results
1. The expression of FHIT
The positive expression rates of FHIT displayed a decreasing level from chronic cervicitis group,different CIN groups to cervical cancer group.The positive expression of FHIT in chronic cervicitis tissus was significantly higher than in CIN tissues (χ2=4.335, P<0.05) and cervical squamous cell cancer tissus (χ2=22.256, P<0.05).There was no statistically difference between CIN I and CIN II-III(P>0.05).There was statistically differrence between CIN group and squamous cell cancer group (χ2=12.266, P<0.05). The positive expression of FHIT in cervical squamons cell cancer groups was related to histological grading and lymph node metastasis,(P<0.05), which had nothing to do with the pathological type and age (P>0.05).
2. The expression of MDM2
The positive expression rates of MDM2displayed a increasing level from chronic cervicitis group,different CIN groups to cervical cancer group. The positive expression of MDM2in chronic cervicitis tissues was significantly lower than in CIN tissues (χ2=5.294, P<0.05)and cervical squannous cellcancer tissus (χ2=22.256, P<0.05). There was no statistically difference between CIN I and CIN Ⅱ-Ⅲ (P>0.05).There was statistically differrence between CIN group and squamous cancer group (χ2=14.042, P<0.05). The expression of MDM2in different cervical squamons cancer groups was not corelated with different ages (P>0.05),but significantly related with clinical stage, histological grade and lymph node mestastasis (P<0.05). The positive expression of MDM2in cervical squamons cell cancer groups was related to pathological type,histological grading and lymph node metastasis,(P<0.05), which had nothing to do with age (P>0.05).
3. The correlation between FHIT and MDM2in different cervical squa-mous cell cancer tissues
The expression of FHIT and MDM2were obviously inverse correlation (χ2=16.563,r=-0.576,P<0.01)
Conclusions
1. FHIT might play an important role in the occurence of cervical squamous cell carcinoma.
2. MDM2might participate in the occurence and development of cervical squamous cell carcinoma.
3. Both FHIT and MDM2might participate in the metasitasis of cervical squamous cell carcinoma.
4. The FHIT expression was negatively correlated to MDM2expression, indicating that loss expression of FHIT and overexpression of MDM2might promote proliferation and metastasis of malignant tumor.
引文
[1]Parkin D M, Bray F, Ferlay J, etal.Global cancer statistics,2002[J]. CA Cancer J Clin,2005, 55 (02):74-108.
[2]徐建云,钱建华,周彩云等宫颈鳞状上皮细胞癌变过程中细胞周期调节通路p14ARF-MDM2-p53作用的研究[J].科技通报,2007,23(01)：58-62
[3]Ohta M, Cotticelli M G, Inoue H, etal. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3,8) break point, is abnormal in digestive tract cancers [J]. CELL,1996,84(04):587-597.
[4]罗静,陶光实FHIT基因与宫颈癌研究的新进展[J].中国妇幼健康研究,2006,17(06)：534-537.
[5]Xiao GH, Klein-Szanto AJP, Jin F, etal. The FHIT gene product is highly expressed in the cytoplasm of renal tubular epithelium and is down-regulated in kidney cancers [J]. Am J Pathol,1997,151 (01):1541-1546.
[6]Agathanggelou A, Ahmed-Choudhury J, Biechei, etal.Identification of nOvel gene express expression targets for the Ras association domain family 1 (RASSF 1 A) tumor supressor gene in non-small cell lung cancer and neuro blastoma [J].Cancer Res,2003, 63 (17):5344-5350.
[7]张鸿瑞,何纯年.鼠的双微体基因2与P53在子宫颈癌发生中的作用[J].中国医疗前沿,2008,16(3)：5-9.
[8]王东红,邓卫安.mdm2癌基因与宫颈癌致病机制[J].医学综述,2005,11(3)：256-257.
[9]王宁,李旭日,姚勤等.在宫颈鳞癌组织中p53和mdm2蛋白异常表达的研究[J].中,国肿瘤,2004,13(6)：385-388.
[10]Connolly D C, Wu R, Grecnspan D L, etal.Loss of FHIT expression in invasive cervical carcinomas and intraepitheial lesions associated with invasive disease[J]. Clin Cancer Res, 2000,6(9):3505-3510.
[11]Wanger KU, Qi Y, Krempler A, etal.TSG 101 is essential for cell growth, proliferation, and cell survival of embryonic and adult tissues[J]. MoL Cell Biol,2003,23(01):150-162.
[12]Zhang SL, Wang YS, Zhou T,et al. Isolation and characterization of cancer stem cells from cervical cancer HeLa cells. Cytotechnology,2012,2 (01):37-42.
[13]Garrison PN, Sipra shvili Z, Barnes LD, etal. Fhit, a putative tumor supressor in humans, is an dinucleoside 5',5 "'-P-1.P-3-trip hosphatte hydrolasee[J]. Biochemisstry,1996,35 (36):11529-11535.
[14]Bing Nishizaki, Ji-chiro Sasaki, Masahiko-liang Fang, etal. Synergistic Tumor Supression by Coexpression of FHIT and P53 Coincides with FHIT-Mediated MDM2 inactivationand p53 Stabilization in Human Non-Small Cell Lung Cancer [J]. Cancer Res,2004,64 (0 8):5745-5752.
[15]Sozzi G, Croce CM, Huebner K. Role of FHIT in human cancer [J]. Clin Oncol,1999,17 (05):1618-1624.
[16]陈燕雄,李忠东.外源性的FHIT基因表达对顺铂诱导的宫颈癌Si Ha细胞系凋亡的影响[J].现代妇产科进展,2006,15(01)：46-49.
[17]Gramegna M, Roz L, Ishi H, etal. Restoration of Fragile Histidine Triad (FHIT) expression induces apopptosis and supress tumor igenicity in Lung and cervical cancer cell lines[J]. Proc Natl Acad SCi USA,2002,99 (06):3615-3620.
[18]Trapasso F, Semba S, Fabbri M, etal. Fhit modulation of the Akt-survivin pathway in lung cancer cells:Fhit-tyrisine 114 (Y 114) is essential [J]. Oncogene,2006,25(20): 2860-2872.
[19]Bianchi F, Campiglio M, Riani F, etal. Disdeno sinsas FHITness instructors [J]. J Cell Physiol,2006,208 (02):274-281.
[20]林晨,陈锐,拉莱.苏祖克.新疆地区的妇女宫颈癌及CIN中FHIT和MSH2蛋白表达和意义[J].中国现代医学杂志,2011,21(01)：69-72.
[21]Veuhione A, Eanesi N, T Rrombett A G, etal. Cervical dysplasia ploidy and human papil loma virus statis correlate with loss of Fhit expression [J]. Clin Cancer Res,2007,7 (05) 1306-1312.
[22]M.D, Lee-Wen Huang, Shiouh-Limg Chao, etal.Reduced FH IT exprssion in cervical care inoma:correlation with tumor progression and poor prognosis [J].Gynec Ologic Oncology,2003,90 (02):331-337.
[23]李杰,朱丹,张小平等.FHIT蛋白在宫颈上皮内瘤变及宫颈癌发生发展中的表达及意义[J].中国妇幼保健,2011,26(25)：3955-3957.
[24]Thomas C Krivak, John W. MCB room, Jeffery Seidman, etal.Abnomal fragile histidine triad (FHIT) expression in advanced cervical carcinoma:a poor prognostic factor [J]. Cancer Res,2006,61 (12):4382-4385.
[25]Zhen MH, Jin ZY, Li H, etal. The change and clinical implication of vascular endothelial function by patients with restenosis of PTCA [J]. China Journal of Modern Medicine,2005, 15(18):2792-2794.
[26]Trochon V, Mabilat C, Bert rand P, etal. Evidence of involvement of C D 44 in endothelial cell proliferation, migration and angiogenes in vitro [J]. Int J Cancer,1996,66(05):664-668.
[27]Lord RS,Ozmen J, Bobryshev YV. CD 40 co-stimulatory molecule expression by dend ritic cells in primary atherosclerotic lesion in carotid arteries and in stenotic saphenous vein cor onary artery graftis [J]. Cardli ovasc Surg,2007,9 (04):329-333.
[28]Cipolone F, Desideri G, Ferri C, etal. Preprocedural level of solublle CD 40 is predictive of enhanced in flammattory response and restenosis after coronary angioplasty [J]. Circu Lation,2003,108 (22):2776-2782.
[29]Aicher A,Urbich C, Dernbach E, etal. CD 40 ligand in hibits endothellial cell migration by increassing production of endothelial reactive oxygen species[J].Circulation,2002,106 (06):981-986.
[30]Pardee A B, Ronos tajski R M, Goidberg A L. Energy requirement for degradation of tum-or associated protein p53 [J].CeII,1984,4 (07):442-448.
[31]葛秀君,李英勇,刘志辉.mdm2蛋白在子宫颈鳞癌中的表达及其意义[J].广东医学,2007,28(03)：404-405
[32]张延平,李惠平.p53的核输入功能在鼠双微体2调节的p 53蛋白降解和泛素化过程中的作用[J].中华肿瘤杂志,2005,27(02)：86-89.
[33]Jun Z, Rongli L,Weihua T.The Expression and the Significance of Smac and MDM2 Proteins in Squamous Cellof Cervical Carcinoma[J]. China Foreign Medical Treatment, 2010,42(07):8-10.
[34]陈利友,周彩云,石一复等.CIN和子宫颈鳞癌的HPV16或18感染与p53、MDM2蛋自表达的关系[J].实用肿瘤杂志,2005,20(08)：500-503.
[35]王昱,王金红,李素红.肿瘤的相关基因蛋白和人乳头瘤病毒在宫颈鳞癌组织中的表达及意义[J].世界中西医结合杂志,2007,11(02)：651-654.
[1]Huibregtse JM, Beau denon S. Human papilloma virus E6 protein, E6 AP and cevical cancer [J]. BMC Biochem,2008,9 (Suppl 1):S 4.
[2]Hamoudi R A, ELhamidi A, Kocjan G, etal.Cervical Intra epithelial Neoplasia:Prognosis by Combined LOH AnalySis of Multipke Loci [J].Gynecolo Oncolo,2004,94(03):671-680.
[3]Haris C C. Structcure and function of the p53 tumor suppresor gene:clues for rational cancer therapeutical strategies [J]. J NatI Cancer lnst (Bethesda),1999,88(20):1442-1455.
[4]李杰,崔丽峰,姜赛琳等.宫颈病变中HPV感染与FHIT蛋白表达的相关性[J].中国妇幼保健,2011,36(26)：5699-5791.
[5]Guang-shi Tao, Jing Luo. Progress in study on correlation between fragile histidine gene and cervical carcinoma [J]. Chinese Journal of Maternal and Child Health Research, 2006,17(06):534-537.
[6]Barnes LD, Garrison PN, Sipra shvili Z, etal. Fhit,a putative tumor suppressor in humans,is a dinucleo side 5',5'"-P1,P 3 - tripho sphate hydrolase [J].Bio chemistry,1996,35(36): 11529-11535.
[7]李惠新,李敏,王小娇.FHIT基因、HPV16E6的表达与宫颈鳞癌发病的相关性研究[J].国际妇产科学杂志,2011,(04)：332-334+338+375.
[8]Accomero P, Sard L, Tornielle S, etal. The tumor-suppressor gene FHIT is invived in the regulation of apoptosis in cell cycle control[J]. Proc Nat 1A cad Sci USA,1999,96 (15):8489-8492.
[9]Sonoshita M, Fujishita T, Doi Y, etal. Development of spontaneous tumours and intestinal lesions in Fhit gene knockout mice[J]. Br J Cancer,2004,91(08):1571-1574.
[10]Andriani F,Camiglio M, Bianchi F, etal. Diadenosines as Fhitness instructors [J]. J Cell Physiol,2006,208 (02):274-281.
[11]李林卿,庄文欣,李鹏程,等.乳腺癌组织FHIT表达及与ER和PR表达的相关性分析[J].实用医药杂志,2011,28(05)：396-398.
[12]Fong K M,Zochbauer M S,Maitra A,etal.5'-CpG island met hyiation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer [J].Cancer Res,2001,61 (09):3581-3585.
[13]Robinson A K,Garrison P N, Pekarsky Y.etal.Phosphorylarion of the human Fhit tumor suppressor on tyrosine 114-in Escherchia coil and unexpected steady state kinetics of the phosphorylated forms[J].Biochemistry,2005,44(16):6286-6292.
[14]陈忠东,李燕雄.外源性FHIT基因表达对利用顺铂诱导的宫颈癌SiHa细胞凋亡的影响[J].现代妇产科进展,2006,15(01)：46-49.
[15]Pecherzewska R, Nawrot B. FHIT:tumor suppessor protein involved in induction of apo-ptosis and cell cycle regulation [J]. Postepy Biochem,2009,55(01):66-75.
[16]Taylor R, Hendricks D T, Reed M, etal. FHIT gene expression in human ovarian, endo-metrial and cervical cancer cell lines[J]. Cancer Res,1997,57(11):2112-2115.
[17]Tanimoto K, Hayashi S, Hajiro - Nakanishi K,etal. Abnormal FHIT transcripts in human breast carcinomas:a clinico pathological and epidemiological analysis of 61 Japanese cases [J]. Cancer Res,2007,57(10):1981-1985.
[18]Hadaczek P, Druck T, Fu T B, etal. Structure and expression of the human FHIT gene in normal and tumor cells[J]. Cancer Res,1997,57(03):504-512.
[19]Thelin S, Panagopoulos I, Mertens F, etal. Variable FHIT transcripts in non-neoplastic tissues [J]. Genes chromosomes cancer,1997,19(04):215-219.
[20]Qiao-Tao Ye, Ya-Hua Lan. The research and development on FHIT gene[J]. Overseas Med-Radiation & Nucleus Fascicule,2001,25 (06):275-278.
[21]Grecnspan D L, Connolly D C, Wu R, etal. Loss of FhIT expression in invas ive cervical carcinomas and intraepithelial lesions associated with invasive dise ase[J].Clin Cancer Res, 2000,6(09):3505-3510.
[22]Lee-Wen Huang, M.D, Shiouh-Lirng Chao,etal.Reduced FHIT expression in cervical carcinoma:correlation with tumor progression and poor prognosis [J].Gyneco Logic Oncology,2003,90 (2):331-337.
[23]Nguyen D, Roth JA, Lawrence DD. etal. Retro virus-mediated wild-tpye p53 gene Transfer to tumors of patients with lung cancer. Nat Med,1996,2(09):985-991.
[24]Mori M, Mimori K, Shiraishi T,etal.Altered expression of Fhit in carcinoma and precar cinomatous lesions of the esophagus [J].Cancer Res,2000,60(05):1177-1180.
[25]Ohta M, Inoue H, Cotticelli M G, etal. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3,8) break point, is abnormal in digestive tract cancers [J]. Cell,1996,84(04):587-597.
[26]Huang L W,Chao S L, Chen T J.Reduced it expression in cervicao carcinoma:correlation with tumor progression and poor prognosis[J].GynecolOncok,2003,90(02):331-337.
[27]Meng L, Wu Y, Wang H, etal. Regulation of DNA methylation on the expression of the FHIT gene contributes to cervical carcinoma cell tumorigenesis [J]. Oncol Rep,2006,16 (03):625-629.
[28]Yoo J S,Kim C H, Lee C T,etal. FHIT protein enhances paclitaxel induced apoptos is in Lung cancer cells [J]. Int J Cancer,2005,118(07):1692-1698.
[29]Masahiko Nishizaki, Ji-chiro Sasaki, Bing-liang Fang, etal. Synergistic Tumor Suppre-ssion by Coexpression of FHIT and p53 Coincides with FHIT-Mediated MDM2 inactivation and p53 Stabilization in Human Non-Small Cell Lung Cancer[J]. Cancer Res, 2004,64(16):5745-5752.
[30]Hiroshi Tsuda, Yasunori Hashiguchi, Sadako Nishimur,etal. Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm [J]. Gynecologic Oncology,2003,91(03):476-485.
[31]Scheetheiss E, Dellas A, Almendral A, etal. Altered expression of mdm2 and it's associ ation with p53 prote in status, tumor cell proliferation rate and prognosis in cervical neopLasia[J].Cancer,1997,74(09):421-425.
[32]董华洁MDM2-p53-miR-34通路在慢性淋巴细胞白血病中的作用机制研究[D].导师：李建勇,徐卫.南京医科大学,2011.
[33]Ying Z, Xiao ming L, Tao Z.The expression of P53,MDM2 and their associations with proliferating cell nuclear antigen in cervical intra-epithelial neoplasm and cervical carcinoma[J].Cancer,2000,19(07):659-662.
[34]Trusko S P, Fakharzadeh S S, George D L. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line [J]. EMBO J,1991, 10(06):1565-1569.
[35]Xia K D, Cheng X M, Lin Q A, etal. Study of expression of heat shock protein 70, P53, and Bel-2-in cervical cancer and their correlation[J]. China Journal of Modern Medicine, 2005,15 (02):253-255.
[36]Levine AJ. p53, the cellular gate keeper for growth and division[J]. Cell,1997,88 (0 3):323-31.
[37]Momand J,Zam betti GP,Olson DC.etal.The mdm-2 oncogen product forms a complex with the p53 protein and inhabits p53 mediated transactivation[J].Cell,1992,69(07) 1237-1245.
[38]Sherr C J, Lowe S W,. Tumor Suppression by ink 4a-Arf:progess and puzzles [J]. Curropin Genet DeV,2003,113(01):77-83.
[39]Lamed Y, Berkovich E, Ginsberg D. E-2F and Ras synergize in transcription altyactiating pl4 ARF expression [J].Cell Cycle,2003,2(02):127-133.
[40]Freedman DA, Levine AJ. Regulation of the p53 protein by the MDM2 oncoprotein: thirty-eighth G. H. A. Clowes Memorial Award Lecture[J]. Cancer Res,1999,59(01):1-7.
[41]Geyer RK, Yu ZK, Maki CG. MDM2-dependent ubiquitination of nuclear and cytoplasmic P53[J]. Oncogene 2000,19(51):5892-5897.
[42]Goldberg A L, Ronostajski R M, Pardee A B. Energy requirement for degradation of tumor associated protein p53 [J].Cell,1984,4 (07):442-448.
[43]Kristensen G B, SkomedaL H, Lie A K, etal. Aber cyclin DI, RB and EGFR in cervical carcinomas[J]. Gynecol Oncol,1999,73 (02):223-228.
[44]Liu L, Reifenberger G, Collins V P, etal. Analysis of glioma cell lines for amplification and overexpression of mdm2 [J]. Cell,1994,11 (06):91-96.
[45]孙丽君,杨炳,明祖谦等.p53、MDM2蛋白在宫颈癌中的表达及相关性的研究[J].贵州医,2007,31(01)：1-2.
[46]赵俊军,时淑珍,赵卫红等FHIT和mdm 2蛋白在非小细胞型肺癌中的表达及意义[J].临床肿瘤学,2009,14(03)：212-216.
[47]温春燕,尹晓敏,韩玉玲等FHIT和MDM 2在口腔黏膜下的纤维性变及其癌变组织中 的表达[J].中南大学学报(医学版),2010,35(06)：572-575.
[48]Abbas HA, Pant V, Lozano G. Mdm2:the ups and downs[J]. Cell Cycle,2011,10(19): 3257-62.
[49]Szulc A, Golebiowski F, Szutowicz A, etal. Ubc 92 induced in hibition of diadeno sine triphosphate hydrolase activity of the putative tumor suppressor protein fhit[J]. Arch Biochem Biophys,2004,428(02):160-164.
[50]Robinson A K,]Garrison P N, Pekarsky Y, etal. Phosphorylation of the human Fhit tumor suppressor on tyrosine 114 in Escherichia coli and unexpected steady state kinetics of the phosphory lated forms [J].Bio Chemistry,2005,44(16):6286-6292.
[51]Ishii H, Mimori K, Nagahara H, etal. FHIT is up-regulated by in flammatory stimuli and inhibits prostagl and in E2 mediated carcinoma progression[J]. Carcinoma Res,2006,66 (05):2683-2690.
[52]Trapasso F, Semba S, FabbriM, etal. Fhit moduLation of the Akt2 survivin pathway in lung carcinoma cells:Fhit tyrosine 114 (Y114) is essential[J]. Oncogene,2006,25 (20) 2860-2872.
[53]Kinzler KW, Oliner JD, Melt zer PS, etal. DNA damage stress induces the dissociation of Smurfl/2 from MDM2 in a slow manner[J].Chinese Science Bulletin,2011,30(01):3155-3161.
[54]Chaudhuri AR, Khan LA, Prasad V, etal.The tumor suppress or protein FHIT:A novel interaction with tubulin[J].Biol Chem,1999,274(34):24378-24382.
[55]韩鹏,付鹏,姜延军等.小鼠双微体扩增基因的反义寡核苷酸在血管平滑肌的细胞中的摄取动力学的研究[J].哈尔滨医科大学学报,2011,45(05)：405-408.
[56]Xin-Hua Zhou, Hui-Ling Li, Xue-Ping Huang, etal. Correlation of Seven Biological Factors (Hsp90a, p53, MDM2, Be 12,Bax,Cyto chrome C, and Cleaved caspase3) with Clinical Out comes of ALK+Anap lastic Large cell Lymphoma[J]. Biomed Environ Sci, 2011,24(06):630-641.
[57]Asish R. Chaudhuri I, Israr A. Khan, Veena Prasad,etal. The Tumor Suppressor Protein Fhit (A NOVEL INTERA CTION WITH TUB ULIN) [J]. Biochemistry and Molecular Biology, Inc,1999,274 (34):24378-24382.
[58]薛晓辰,王立岩FHIT、Bcl-2及Bax在宫颈癌中的表达及意义[J].·吉林医学,2012,33(07)：1401-1403.
[59]崔华英,周栩茹,韩庆等.5-氮杂胞苷对宫颈癌细胞FHIT基因去甲基化及抑制增殖作用[J].中国妇幼保健,2012,27(06)：900-902.
[60]张舵舵,赵燕颖,张妍等.siRNA抑制人胶质瘤细胞MDM2的表达及细胞增殖[J].中国实验诊断学,2011,15(06)：995-997.
[61]陈珂瑶.维药异常黑胆质成熟剂总酚对宫颈癌SiHa细胞株体外生长的影响[D].导师：古扎丽努尔·阿不力孜.新疆医科大学,2011.
[2]徐建云,钱建华,周彩云等宫颈鳞状上皮细胞癌变过程中细胞周期调节通路p14ARF-MDM2-p53作用的研究[J].科技通报,2007,23(01)：58-62
[3]Ohta M, Cotticelli M G, Inoue H, etal. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3,8) break point, is abnormal in digestive tract cancers [J]. CELL,1996,84(04):587-597.
[4]罗静,陶光实FHIT基因与宫颈癌研究的新进展[J].中国妇幼健康研究,2006,17(06)：534-537.
[5]Xiao GH, Klein-Szanto AJP, Jin F, etal. The FHIT gene product is highly expressed in the cytoplasm of renal tubular epithelium and is down-regulated in kidney cancers [J]. Am J Pathol,1997,151 (01):1541-1546.
[6]Agathanggelou A, Ahmed-Choudhury J, Biechei, etal.Identification of nOvel gene express expression targets for the Ras association domain family 1 (RASSF 1 A) tumor supressor gene in non-small cell lung cancer and neuro blastoma [J].Cancer Res,2003, 63 (17):5344-5350.
[7]张鸿瑞,何纯年.鼠的双微体基因2与P53在子宫颈癌发生中的作用[J].中国医疗前沿,2008,16(3)：5-9.
[8]王东红,邓卫安.mdm2癌基因与宫颈癌致病机制[J].医学综述,2005,11(3)：256-257.
[9]王宁,李旭日,姚勤等.在宫颈鳞癌组织中p53和mdm2蛋白异常表达的研究[J].中,国肿瘤,2004,13(6)：385-388.
[10]Connolly D C, Wu R, Grecnspan D L, etal.Loss of FHIT expression in invasive cervical carcinomas and intraepitheial lesions associated with invasive disease[J]. Clin Cancer Res, 2000,6(9):3505-3510.
[11]Wanger KU, Qi Y, Krempler A, etal.TSG 101 is essential for cell growth, proliferation, and cell survival of embryonic and adult tissues[J]. MoL Cell Biol,2003,23(01):150-162.
[12]Zhang SL, Wang YS, Zhou T,et al. Isolation and characterization of cancer stem cells from cervical cancer HeLa cells. Cytotechnology,2012,2 (01):37-42.
[13]Garrison PN, Sipra shvili Z, Barnes LD, etal. Fhit, a putative tumor supressor in humans, is an dinucleoside 5',5 "'-P-1.P-3-trip hosphatte hydrolasee[J]. Biochemisstry,1996,35 (36):11529-11535.
[14]Bing Nishizaki, Ji-chiro Sasaki, Masahiko-liang Fang, etal. Synergistic Tumor Supression by Coexpression of FHIT and P53 Coincides with FHIT-Mediated MDM2 inactivationand p53 Stabilization in Human Non-Small Cell Lung Cancer [J]. Cancer Res,2004,64 (0 8):5745-5752.
[15]Sozzi G, Croce CM, Huebner K. Role of FHIT in human cancer [J]. Clin Oncol,1999,17 (05):1618-1624.
[16]陈燕雄,李忠东.外源性的FHIT基因表达对顺铂诱导的宫颈癌Si Ha细胞系凋亡的影响[J].现代妇产科进展,2006,15(01)：46-49.
[17]Gramegna M, Roz L, Ishi H, etal. Restoration of Fragile Histidine Triad (FHIT) expression induces apopptosis and supress tumor igenicity in Lung and cervical cancer cell lines[J]. Proc Natl Acad SCi USA,2002,99 (06):3615-3620.
[18]Trapasso F, Semba S, Fabbri M, etal. Fhit modulation of the Akt-survivin pathway in lung cancer cells:Fhit-tyrisine 114 (Y 114) is essential [J]. Oncogene,2006,25(20): 2860-2872.
[19]Bianchi F, Campiglio M, Riani F, etal. Disdeno sinsas FHITness instructors [J]. J Cell Physiol,2006,208 (02):274-281.
[20]林晨,陈锐,拉莱.苏祖克.新疆地区的妇女宫颈癌及CIN中FHIT和MSH2蛋白表达和意义[J].中国现代医学杂志,2011,21(01)：69-72.
[21]Veuhione A, Eanesi N, T Rrombett A G, etal. Cervical dysplasia ploidy and human papil loma virus statis correlate with loss of Fhit expression [J]. Clin Cancer Res,2007,7 (05) 1306-1312.
[22]M.D, Lee-Wen Huang, Shiouh-Limg Chao, etal.Reduced FH IT exprssion in cervical care inoma:correlation with tumor progression and poor prognosis [J].Gynec Ologic Oncology,2003,90 (02):331-337.
[23]李杰,朱丹,张小平等.FHIT蛋白在宫颈上皮内瘤变及宫颈癌发生发展中的表达及意义[J].中国妇幼保健,2011,26(25)：3955-3957.
[24]Thomas C Krivak, John W. MCB room, Jeffery Seidman, etal.Abnomal fragile histidine triad (FHIT) expression in advanced cervical carcinoma:a poor prognostic factor [J]. Cancer Res,2006,61 (12):4382-4385.
[25]Zhen MH, Jin ZY, Li H, etal. The change and clinical implication of vascular endothelial function by patients with restenosis of PTCA [J]. China Journal of Modern Medicine,2005, 15(18):2792-2794.
[26]Trochon V, Mabilat C, Bert rand P, etal. Evidence of involvement of C D 44 in endothelial cell proliferation, migration and angiogenes in vitro [J]. Int J Cancer,1996,66(05):664-668.
[27]Lord RS,Ozmen J, Bobryshev YV. CD 40 co-stimulatory molecule expression by dend ritic cells in primary atherosclerotic lesion in carotid arteries and in stenotic saphenous vein cor onary artery graftis [J]. Cardli ovasc Surg,2007,9 (04):329-333.
[28]Cipolone F, Desideri G, Ferri C, etal. Preprocedural level of solublle CD 40 is predictive of enhanced in flammattory response and restenosis after coronary angioplasty [J]. Circu Lation,2003,108 (22):2776-2782.
[29]Aicher A,Urbich C, Dernbach E, etal. CD 40 ligand in hibits endothellial cell migration by increassing production of endothelial reactive oxygen species[J].Circulation,2002,106 (06):981-986.
[30]Pardee A B, Ronos tajski R M, Goidberg A L. Energy requirement for degradation of tum-or associated protein p53 [J].CeII,1984,4 (07):442-448.
[31]葛秀君,李英勇,刘志辉.mdm2蛋白在子宫颈鳞癌中的表达及其意义[J].广东医学,2007,28(03)：404-405
[32]张延平,李惠平.p53的核输入功能在鼠双微体2调节的p 53蛋白降解和泛素化过程中的作用[J].中华肿瘤杂志,2005,27(02)：86-89.
[33]Jun Z, Rongli L,Weihua T.The Expression and the Significance of Smac and MDM2 Proteins in Squamous Cellof Cervical Carcinoma[J]. China Foreign Medical Treatment, 2010,42(07):8-10.
[34]陈利友,周彩云,石一复等.CIN和子宫颈鳞癌的HPV16或18感染与p53、MDM2蛋自表达的关系[J].实用肿瘤杂志,2005,20(08)：500-503.
[35]王昱,王金红,李素红.肿瘤的相关基因蛋白和人乳头瘤病毒在宫颈鳞癌组织中的表达及意义[J].世界中西医结合杂志,2007,11(02)：651-654.
[1]Huibregtse JM, Beau denon S. Human papilloma virus E6 protein, E6 AP and cevical cancer [J]. BMC Biochem,2008,9 (Suppl 1):S 4.
[2]Hamoudi R A, ELhamidi A, Kocjan G, etal.Cervical Intra epithelial Neoplasia:Prognosis by Combined LOH AnalySis of Multipke Loci [J].Gynecolo Oncolo,2004,94(03):671-680.
[3]Haris C C. Structcure and function of the p53 tumor suppresor gene:clues for rational cancer therapeutical strategies [J]. J NatI Cancer lnst (Bethesda),1999,88(20):1442-1455.
[4]李杰,崔丽峰,姜赛琳等.宫颈病变中HPV感染与FHIT蛋白表达的相关性[J].中国妇幼保健,2011,36(26)：5699-5791.
[5]Guang-shi Tao, Jing Luo. Progress in study on correlation between fragile histidine gene and cervical carcinoma [J]. Chinese Journal of Maternal and Child Health Research, 2006,17(06):534-537.
[6]Barnes LD, Garrison PN, Sipra shvili Z, etal. Fhit,a putative tumor suppressor in humans,is a dinucleo side 5',5'"-P1,P 3 - tripho sphate hydrolase [J].Bio chemistry,1996,35(36): 11529-11535.
[7]李惠新,李敏,王小娇.FHIT基因、HPV16E6的表达与宫颈鳞癌发病的相关性研究[J].国际妇产科学杂志,2011,(04)：332-334+338+375.
[8]Accomero P, Sard L, Tornielle S, etal. The tumor-suppressor gene FHIT is invived in the regulation of apoptosis in cell cycle control[J]. Proc Nat 1A cad Sci USA,1999,96 (15):8489-8492.
[9]Sonoshita M, Fujishita T, Doi Y, etal. Development of spontaneous tumours and intestinal lesions in Fhit gene knockout mice[J]. Br J Cancer,2004,91(08):1571-1574.
[10]Andriani F,Camiglio M, Bianchi F, etal. Diadenosines as Fhitness instructors [J]. J Cell Physiol,2006,208 (02):274-281.
[11]李林卿,庄文欣,李鹏程,等.乳腺癌组织FHIT表达及与ER和PR表达的相关性分析[J].实用医药杂志,2011,28(05)：396-398.
[12]Fong K M,Zochbauer M S,Maitra A,etal.5'-CpG island met hyiation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer [J].Cancer Res,2001,61 (09):3581-3585.
[13]Robinson A K,Garrison P N, Pekarsky Y.etal.Phosphorylarion of the human Fhit tumor suppressor on tyrosine 114-in Escherchia coil and unexpected steady state kinetics of the phosphorylated forms[J].Biochemistry,2005,44(16):6286-6292.
[14]陈忠东,李燕雄.外源性FHIT基因表达对利用顺铂诱导的宫颈癌SiHa细胞凋亡的影响[J].现代妇产科进展,2006,15(01)：46-49.
[15]Pecherzewska R, Nawrot B. FHIT:tumor suppessor protein involved in induction of apo-ptosis and cell cycle regulation [J]. Postepy Biochem,2009,55(01):66-75.
[16]Taylor R, Hendricks D T, Reed M, etal. FHIT gene expression in human ovarian, endo-metrial and cervical cancer cell lines[J]. Cancer Res,1997,57(11):2112-2115.
[17]Tanimoto K, Hayashi S, Hajiro - Nakanishi K,etal. Abnormal FHIT transcripts in human breast carcinomas:a clinico pathological and epidemiological analysis of 61 Japanese cases [J]. Cancer Res,2007,57(10):1981-1985.
[18]Hadaczek P, Druck T, Fu T B, etal. Structure and expression of the human FHIT gene in normal and tumor cells[J]. Cancer Res,1997,57(03):504-512.
[19]Thelin S, Panagopoulos I, Mertens F, etal. Variable FHIT transcripts in non-neoplastic tissues [J]. Genes chromosomes cancer,1997,19(04):215-219.
[20]Qiao-Tao Ye, Ya-Hua Lan. The research and development on FHIT gene[J]. Overseas Med-Radiation & Nucleus Fascicule,2001,25 (06):275-278.
[21]Grecnspan D L, Connolly D C, Wu R, etal. Loss of FhIT expression in invas ive cervical carcinomas and intraepithelial lesions associated with invasive dise ase[J].Clin Cancer Res, 2000,6(09):3505-3510.
[22]Lee-Wen Huang, M.D, Shiouh-Lirng Chao,etal.Reduced FHIT expression in cervical carcinoma:correlation with tumor progression and poor prognosis [J].Gyneco Logic Oncology,2003,90 (2):331-337.
[23]Nguyen D, Roth JA, Lawrence DD. etal. Retro virus-mediated wild-tpye p53 gene Transfer to tumors of patients with lung cancer. Nat Med,1996,2(09):985-991.
[24]Mori M, Mimori K, Shiraishi T,etal.Altered expression of Fhit in carcinoma and precar cinomatous lesions of the esophagus [J].Cancer Res,2000,60(05):1177-1180.
[25]Ohta M, Inoue H, Cotticelli M G, etal. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3,8) break point, is abnormal in digestive tract cancers [J]. Cell,1996,84(04):587-597.
[26]Huang L W,Chao S L, Chen T J.Reduced it expression in cervicao carcinoma:correlation with tumor progression and poor prognosis[J].GynecolOncok,2003,90(02):331-337.
[27]Meng L, Wu Y, Wang H, etal. Regulation of DNA methylation on the expression of the FHIT gene contributes to cervical carcinoma cell tumorigenesis [J]. Oncol Rep,2006,16 (03):625-629.
[28]Yoo J S,Kim C H, Lee C T,etal. FHIT protein enhances paclitaxel induced apoptos is in Lung cancer cells [J]. Int J Cancer,2005,118(07):1692-1698.
[29]Masahiko Nishizaki, Ji-chiro Sasaki, Bing-liang Fang, etal. Synergistic Tumor Suppre-ssion by Coexpression of FHIT and p53 Coincides with FHIT-Mediated MDM2 inactivation and p53 Stabilization in Human Non-Small Cell Lung Cancer[J]. Cancer Res, 2004,64(16):5745-5752.
[30]Hiroshi Tsuda, Yasunori Hashiguchi, Sadako Nishimur,etal. Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm [J]. Gynecologic Oncology,2003,91(03):476-485.
[31]Scheetheiss E, Dellas A, Almendral A, etal. Altered expression of mdm2 and it's associ ation with p53 prote in status, tumor cell proliferation rate and prognosis in cervical neopLasia[J].Cancer,1997,74(09):421-425.
[32]董华洁MDM2-p53-miR-34通路在慢性淋巴细胞白血病中的作用机制研究[D].导师：李建勇,徐卫.南京医科大学,2011.
[33]Ying Z, Xiao ming L, Tao Z.The expression of P53,MDM2 and their associations with proliferating cell nuclear antigen in cervical intra-epithelial neoplasm and cervical carcinoma[J].Cancer,2000,19(07):659-662.
[34]Trusko S P, Fakharzadeh S S, George D L. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line [J]. EMBO J,1991, 10(06):1565-1569.
[35]Xia K D, Cheng X M, Lin Q A, etal. Study of expression of heat shock protein 70, P53, and Bel-2-in cervical cancer and their correlation[J]. China Journal of Modern Medicine, 2005,15 (02):253-255.
[36]Levine AJ. p53, the cellular gate keeper for growth and division[J]. Cell,1997,88 (0 3):323-31.
[37]Momand J,Zam betti GP,Olson DC.etal.The mdm-2 oncogen product forms a complex with the p53 protein and inhabits p53 mediated transactivation[J].Cell,1992,69(07) 1237-1245.
[38]Sherr C J, Lowe S W,. Tumor Suppression by ink 4a-Arf:progess and puzzles [J]. Curropin Genet DeV,2003,113(01):77-83.
[39]Lamed Y, Berkovich E, Ginsberg D. E-2F and Ras synergize in transcription altyactiating pl4 ARF expression [J].Cell Cycle,2003,2(02):127-133.
[40]Freedman DA, Levine AJ. Regulation of the p53 protein by the MDM2 oncoprotein: thirty-eighth G. H. A. Clowes Memorial Award Lecture[J]. Cancer Res,1999,59(01):1-7.
[41]Geyer RK, Yu ZK, Maki CG. MDM2-dependent ubiquitination of nuclear and cytoplasmic P53[J]. Oncogene 2000,19(51):5892-5897.
[42]Goldberg A L, Ronostajski R M, Pardee A B. Energy requirement for degradation of tumor associated protein p53 [J].Cell,1984,4 (07):442-448.
[43]Kristensen G B, SkomedaL H, Lie A K, etal. Aber cyclin DI, RB and EGFR in cervical carcinomas[J]. Gynecol Oncol,1999,73 (02):223-228.
[44]Liu L, Reifenberger G, Collins V P, etal. Analysis of glioma cell lines for amplification and overexpression of mdm2 [J]. Cell,1994,11 (06):91-96.
[45]孙丽君,杨炳,明祖谦等.p53、MDM2蛋白在宫颈癌中的表达及相关性的研究[J].贵州医,2007,31(01)：1-2.
[46]赵俊军,时淑珍,赵卫红等FHIT和mdm 2蛋白在非小细胞型肺癌中的表达及意义[J].临床肿瘤学,2009,14(03)：212-216.
[47]温春燕,尹晓敏,韩玉玲等FHIT和MDM 2在口腔黏膜下的纤维性变及其癌变组织中 的表达[J].中南大学学报(医学版),2010,35(06)：572-575.
[48]Abbas HA, Pant V, Lozano G. Mdm2:the ups and downs[J]. Cell Cycle,2011,10(19): 3257-62.
[49]Szulc A, Golebiowski F, Szutowicz A, etal. Ubc 92 induced in hibition of diadeno sine triphosphate hydrolase activity of the putative tumor suppressor protein fhit[J]. Arch Biochem Biophys,2004,428(02):160-164.
[50]Robinson A K,]Garrison P N, Pekarsky Y, etal. Phosphorylation of the human Fhit tumor suppressor on tyrosine 114 in Escherichia coli and unexpected steady state kinetics of the phosphory lated forms [J].Bio Chemistry,2005,44(16):6286-6292.
[51]Ishii H, Mimori K, Nagahara H, etal. FHIT is up-regulated by in flammatory stimuli and inhibits prostagl and in E2 mediated carcinoma progression[J]. Carcinoma Res,2006,66 (05):2683-2690.
[52]Trapasso F, Semba S, FabbriM, etal. Fhit moduLation of the Akt2 survivin pathway in lung carcinoma cells:Fhit tyrosine 114 (Y114) is essential[J]. Oncogene,2006,25 (20) 2860-2872.
[53]Kinzler KW, Oliner JD, Melt zer PS, etal. DNA damage stress induces the dissociation of Smurfl/2 from MDM2 in a slow manner[J].Chinese Science Bulletin,2011,30(01):3155-3161.
[54]Chaudhuri AR, Khan LA, Prasad V, etal.The tumor suppress or protein FHIT:A novel interaction with tubulin[J].Biol Chem,1999,274(34):24378-24382.
[55]韩鹏,付鹏,姜延军等.小鼠双微体扩增基因的反义寡核苷酸在血管平滑肌的细胞中的摄取动力学的研究[J].哈尔滨医科大学学报,2011,45(05)：405-408.
[56]Xin-Hua Zhou, Hui-Ling Li, Xue-Ping Huang, etal. Correlation of Seven Biological Factors (Hsp90a, p53, MDM2, Be 12,Bax,Cyto chrome C, and Cleaved caspase3) with Clinical Out comes of ALK+Anap lastic Large cell Lymphoma[J]. Biomed Environ Sci, 2011,24(06):630-641.
[57]Asish R. Chaudhuri I, Israr A. Khan, Veena Prasad,etal. The Tumor Suppressor Protein Fhit (A NOVEL INTERA CTION WITH TUB ULIN) [J]. Biochemistry and Molecular Biology, Inc,1999,274 (34):24378-24382.
[58]薛晓辰,王立岩FHIT、Bcl-2及Bax在宫颈癌中的表达及意义[J].·吉林医学,2012,33(07)：1401-1403.
[59]崔华英,周栩茹,韩庆等.5-氮杂胞苷对宫颈癌细胞FHIT基因去甲基化及抑制增殖作用[J].中国妇幼保健,2012,27(06)：900-902.
[60]张舵舵,赵燕颖,张妍等.siRNA抑制人胶质瘤细胞MDM2的表达及细胞增殖[J].中国实验诊断学,2011,15(06)：995-997.
[61]陈珂瑶.维药异常黑胆质成熟剂总酚对宫颈癌SiHa细胞株体外生长的影响[D].导师：古扎丽努尔·阿不力孜.新疆医科大学,2011.